During the past decade, Medizinische Klinik und Poliklinik A - Universitaetsklinikum Muenster conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Medizinische Klinik und Poliklinik A - Universitaetsklinikum Muenster" #1 sponsor was "German High-Grade Non-Hodgkin's Lymphoma Study Group" with 4 trials, followed by "University Hospital Muenster" with 3 trials sponsored, "Celgene" with 1 trials sponsored, "Celgene Corporation" with 1 trials sponsored and "Christian Buske" with 1 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Medizinische Klinik und Poliklinik A - Universitaetsklinikum Muenster" #1 collaborator was "Amgen" with 1 trials as a collaborator, "Bayer" with 1 trials as a collaborator, "Boehringer Ingelheim" with 1 trials as a collaborator, "Celgene Corporation" with 1 trials as a collaborator and "ClinAssess" with 1 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "Medizinische Klinik und Poliklinik A - Universitaetsklinikum Muenster" are "Lymphoma" (5 trials), "Acute Myeloid Leukemia" (3 trials), "Multiple Myeloma" (2 trials), "CD20+ Aggressive B-Cell Lymphoma" (1 trials) and "Extragonadal Germ Cell Tumor" (1 trials). Many other conditions were trialed in "Medizinische Klinik und Poliklinik A - Universitaetsklinikum Muenster" in a lesser frequency.

Most popular intervention types in "Medizinische Klinik und Poliklinik A - Universitaetsklinikum Muenster" are "Drug" (16 trials), "Biological" (5 trials), "Radiation" (4 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "cyclophosphamide" (5 trials), "doxorubicin hydrochloride" (5 trials), "prednisone" (5 trials), "vincristine sulfate" (5 trials) and "filgrastim" (4 trials). Other intervention names were less common.

The vast majority of trials in "Medizinische Klinik und Poliklinik A - Universitaetsklinikum Muenster" are 14 trials for "All" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Medizinische Klinik und Poliklinik A - Universitaetsklinikum Muenster". undefined are not yet recruiting, undefined are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Medizinische Klinik und Poliklinik A - Universitaetsklinikum Muenster, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Medizinische Klinik und Poliklinik A - Universitaetsklinikum Muenster, 1 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".